| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.078 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |